| Literature DB >> 35891240 |
Saed A Sulub1, Mubarak A Mohamed2,3.
Abstract
Various COVID-19 vaccines have been developed in an unprecedented time and were rolled out across the world to save lives during the COVID-19 pandemic. Yet statistics show that COVID-19 uptake and acceptance in the Horn of Africa have been very low. To examine factors associated with COVID-19 vaccine uptake and acceptance in Somaliland, we carried out a cross-sectional study using a structured questionnaire both in offline and online modes. The study population was adults from the age of 18 years and above. Of the 704 respondents who participated in the survey, only 37% took the vaccine. Surprisingly, about 65% of those who have not taken the vaccine were unwilling to get vaccinated. Using a binomial logistic regression, we find that older people, the more educated and those who are employed are more likely to take the vaccine. Our results also show that the perceived threat of the virus and the perceived safety of the vaccine significantly increase vaccine uptake and acceptance. Results of this study will help the government and other concerned parties shape policies that can boost vaccine uptake and acceptance.Entities:
Keywords: COVID-19 disease; SARS-CoV-2 vaccine; vaccine acceptance; vaccine hesitancy; willingness
Year: 2022 PMID: 35891240 PMCID: PMC9323273 DOI: 10.3390/vaccines10071076
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Measurement of variables.
| Variable | Question/Statement | Code |
|---|---|---|
| Vaccine uptake | Have you taken the COVID-19 vaccine? | 1 = yes, 0 = no |
| Willingness | Are you willing to take the vaccine? | 1 = yes, 0 = no |
| Gender | Participants gender | 0 = female, 1 = male |
| Age | Age group | 0 = 18–24, 1 = 25–34, 2 = 35–44, 3 = 45–55, 4 = older than 55 |
| Education | Level of education | 0 = no education, 1 = primary, 2 = secondary, 3 = undergraduate, 4 = postgraduate |
| Marital status | Marital status | 0 = single, 1 = married, 2 = divorced, 3 = widowed |
| Employment | Are you currently employed? | 1 = yes, 0 = no |
| Health condition | Have you ever been diagnosed with any of the following underlying health conditions (Choose all that apply)?: heart disease, hypertension, diabetes, cancer, HIV/AIDS, Tuberculosis). | 1 if the respondent chooses at least one of the underlying health conditions specified, 0 otherwise |
| Availability | Was the vaccine made available at work/study place or at a nearby health center? | 1 = yes, 0 = no |
| Perceived threat | COVID-19 poses a serious threat to my health | 3 = strongly agree, 2 = agree, 1 = disagree, 0 = strongly disagree |
| Perceived vaccine safety | COVID-19 vaccine is not safe | 3 = strongly disagree, 2 = disagree, 1 = agree, 0 = strongly agree |
| Residence | Region of residence in Somaliland | 1 = Maroodi Jeeh, 2 = Togdheer, 3 = Sahil, 4 = Awdal, 5 = Sool, 6 = Sanaag |
| Language | Language of questionnaire chosen | 1 = English, 2 = Somali |
| Mode | Online survey vs. paper survey | 1 = paper survey, 2 = online survey |
| Social media use | Approximately, how many hours do you use social media per day? | 0 = less than 2 h, 1 = 2 to 4 h, 2 = 5 to 7 h, 3 = more than 7 h |
Vaccine uptake and willingness.
| Group | Obs. | % Vaccinated/Willing | |
|---|---|---|---|
|
| Yes | 259 | 37% |
| No | 5 | 63% | |
|
| Yes | 153 | 35% |
| No | 282 | 65% |
Group comparison tests.
| Variable | Group | Vaccinated | Willingness | ||
|---|---|---|---|---|---|
| Observations (% Vaccinated) | Difference Test | Observations (% Willing) | Difference Test | ||
|
| Female | 279 (34) | −1.186 | 181 (39) | 1.493 |
| Male | 425 (39) | 254 (32) | |||
|
| 18–24 | 296 (27) | 20.979 *** | 214 (33) | 6.244 |
| 25–34 | 240 (40) | 140 (35) | |||
| 35–44 | 77 (54) | 33 (45) | |||
| 45–55 | 49 (43) | 28 (50) | |||
| >55 | 41 (54) | 19 (21) | |||
|
| No education | 55 (18) | 23.599 *** | 44 (34) | 7.321 |
| Primary | 28 (33) | 19 (37) | |||
| Secondary | 63 (36) | 38 (37) | |||
| Undergraduate | 355 (33) | 232 (31) | |||
| Postgraduate | 201 (49) | 100 (46) | |||
|
| Yes | 416 (43) | −4.032 *** | 231 (34) | 0.516 |
| No | 285 (28) | 202 (36) | |||
|
| Yes | 68 (54) | −2.391 ** | 30 (37) | −0.412 |
| No | 378 (39) | 225 (33) | |||
|
| Yes | 106 (45) | −1.954 | 57 (33) | 0.312 |
| No | 598 (35) | 378 (35) | |||
|
| Yes | 532 (86) | −4.456 *** | 306 (69) | 0.582 |
| No | 165 (71) | 125 (72) | |||
|
| Strongly agree | 272 (48) | 22.438 *** | 140 (42) | 14.018 *** |
| Agree | 241(32) | 161 (40) | |||
| Disagree | 129 (28) | 91 (23) | |||
| Strongly disagree | 56 (25) | 40 (15) | |||
|
| Strongly agree | 165 (32) | 5.485 ** | 110 (23) | 7.798 *** |
| Agree | 224 (33) | 147 (36) | |||
| Disagree | 207 (44) | 114 (46) | |||
| Strongly disagree | 100 (39) | 60 (35) | |||
Notes: Diff. Tests are group comparison tests. These are Mann–Whitney tests for binary variables and Kruskal–Wallis tests for other variables; figures between parentheses in difference test columns are p-values. Significance levels are at 1% (***), 5% (**) and 10% (*).
Logistic regression analysis.
| Model 1: Vaccine Uptake | Model 2: Vaccination Willingness | |||||
|---|---|---|---|---|---|---|
| Coeff. | Std. Error | Z-Test | Coeff. | Std. Error | Z-Test | |
|
| −0.236 | 0.197 | −1.20 | −0.269 | 0.234 | −1.15 |
|
| 0.497 *** | 0.090 | 5.30 | 0.254 ** | 0.129 | 1.99 |
|
| 0.364 *** | 0.108 | 3.36 | 0.237 * | 0.135 | 1.75 |
|
| 0.423 ** | 0.216 | 1.96 | −0.315 | 0.255 | −1.24 |
|
| 0.279 | 0.279 | 1.00 | −0.391 | 0.378 | −1.04 |
|
| 0.522 *** | 0.104 | 5.02 | 0.520 *** | 0.134 | 3.88 |
|
| 0.277 *** | 0.093 | 2.96 | 0.335 *** | 0.115 | 2.91 |
|
| 0.820 *** | 0.230 | 3.56 | −0.184 | 0.246 | −0.75 |
|
| −0.077 | 0.110 | −0.70 | 0.103 | 0.118 | 0.78 |
|
| −0.577 *** | 0.197 | −2.92 | −0.509 ** | 0.260 | −1.96 |
|
| 0.207 | 0.199 | 1.04 | −0.089 | 0.247 | −0.36 |
|
| −0.051 | 0.100 | −0.50 | −0.024 | 0.118 | −0.20 |
| Cons | −3.731 *** | 0.677 | −5.51 | −1.483 * | 0.804 | −1.85 |
Note: Model 1 (observations = 661; LR Chi2 = 125.61; p-value = 0.000; Psuedo R2= 14.43%). Model 2 (observations = 409; LR Chi2 = 37.39; p-value = 0.000; Psuedo R2 = 7.08%). Significance levels are at 1% (***), 5% (**) and 10% (*).